LATEST NEWS

Carnegie Technologies Acquires SmartSwitch From Chemring Technology Solutions Combining Forces to Deliver the Most Comprehensive Mobile Wi-Fi Experience Solution

Carnegie Technologies, a leading wireless connectivity solutions provider, announced today its acquisition of the assets of SmartSwitch from Chemring Technology Solutions Ltd, a subsidiary of Chemring Group PLC (LSE: CHG), which pioneered a comprehensive connection management solution for MNOs and MSOs for their Wi-Fi HetNets.  The strategic acquisition of the SmartSwitch assets brings 3GPP ANDSF and Hot Spot 2.0 compliant connection management technology that Carnegie will integrate into its Network Convergence Platform. The acquisition also includes a supporting patent portfolio as well as extensive experience and knowledge that complements that of Carnegie.

The unique approach taken by SmartSwitch targets a consistent user experience across all devices while in the home, at work, on the move and while out and about. The innovation required to deliver such a tailored experience, in all real-world Wi-Fi conditions, has repeatedly demonstrated the value service providers can extract from their Wi-Fi assets today.  Combining the novel and proven SmartSwitch technology with Carnegie’s Network Convergence Platform (NCP), which includes Bandwidth Aggregation, True Gapless Handover, Connection Management and Network Quality Analytics, creates the optimal solution for the future of Wi-Fi integration to deliver the perfect user experience.

The market has shown readiness for bandwidth aggregation technologies such as Multipath TCP (MPTCP).  The combined capability of SmartSwitch and the patented bandwidth aggregation capabilities of the Network Convergence Platform goes directly for the maximum user experience, offering premium aggregation of data links while ensuring the best Wi-Fi has been selected in order to maximize the potential for Wi-Fi usage, which in turn eliminates congestion and cost on the cellular networks.

Paul Posner, CEO of Carnegie Technologies, commented: “Carnegie’s acquisition of the SmartSwitch assets creates an unsurpassed combination of technologies and human capital, including strong patents, the most advanced platform and the best people that complement each other and bring the most powerful products to the marketplace. Many smart devices on the market today have the capability to access more than one network at a time, and we’re committed to ensuring that the users of these devices can benefit from all networks with the optimal user experience.”

David McDonald, Managing Director of Chemring Technology Solutions added:  “We have seen increasing demand for the combination of advanced connection management with bandwidth aggregation, and today’s announcement brings together the best in class in both of those fields.  The combined product suite is going to provide first-class capability in optimizing the Wi-Fi experience and is exactly what is needed for the next generation of smartphone devices.”

Liat

Recent Posts

Tower Semiconductor Secures $1.3 Billion Silicon Photonics Agreements and Reports Strong Q1 2026 Growth

Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…

2 days ago

14 Israeli Cybersecurity Companies Named to the Rising in Cyber 2026 List of the World’s Most Promising Cyber Startups

The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…

2 days ago

Sequent Selected by 15 Canadian Municipalities to Deliver Verifiable, Trust-Based Digital Voting for Elections

More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…

2 days ago

Sheba and Ichilov Medical Centers Join AccuLine’s International Clinical Trial for AI-Driven Early Heart Attack Risk Assessment

The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…

2 days ago

Molex Completes Acquisition of Teramount Ltd.

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…

5 days ago

Immunai Expands Oncology Collaboration, Extending AI-Driven Biomarker and Clinical Insights Through 2027

This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…

5 days ago